These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 17725714)

  • 41. The C terminus of p53 family proteins is a cell fate determinant.
    Harms KL; Chen X
    Mol Cell Biol; 2005 Mar; 25(5):2014-30. PubMed ID: 15713654
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Two new p73 splice variants, gamma and delta, with different transcriptional activity.
    De Laurenzi V; Costanzo A; Barcaroli D; Terrinoni A; Falco M; Annicchiarico-Petruzzelli M; Levrero M; Melino G
    J Exp Med; 1998 Nov; 188(9):1763-8. PubMed ID: 9802988
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Regulation of p73 by Hck through kinase-dependent and independent mechanisms.
    Paliwal P; Radha V; Swarup G
    BMC Mol Biol; 2007 May; 8():45. PubMed ID: 17535448
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Activation of p73 and induction of Noxa by DNA damage requires NF-kappa B.
    Martin AG; Trama J; Crighton D; Ryan KM; Fearnhead HO
    Aging (Albany NY); 2009 Feb; 1(3):335-49. PubMed ID: 20195489
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Regulation of interleukin-6 gene expression by pro-inflammatory cytokines in a colon cancer cell line.
    Legrand-Poels S; Schoonbroodt S; Piette J
    Biochem J; 2000 Aug; 349 Pt 3(Pt 3):765-73. PubMed ID: 10903137
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Wild-type p53 and p73 negatively regulate expression of proliferation related genes.
    Scian MJ; Carchman EH; Mohanraj L; Stagliano KE; Anderson MA; Deb D; Crane BM; Kiyono T; Windle B; Deb SP; Deb S
    Oncogene; 2008 Apr; 27(18):2583-93. PubMed ID: 17982488
    [TBL] [Abstract][Full Text] [Related]  

  • 47. P73 expression in basal layers of head and neck squamous epithelium: a role in differentiation and carcinogenesis in concert with p53 and p63?
    Faridoni-Laurens L; Bosq J; Janot F; Vayssade M; Le Bihan ML; Kaghad M; Caput D; Bénard J; Ahomadegbe JC
    Oncogene; 2001 Aug; 20(38):5302-12. PubMed ID: 11536043
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Alteration of the MDM2-p73-P14ARF pathway related to tumour progression during urinary bladder carcinogenesis.
    Schlott T; Quentin T; Korabiowska M; Budd B; Kunze E
    Int J Mol Med; 2004 Nov; 14(5):825-36. PubMed ID: 15492852
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Receptor tyrosine kinase EphA2 is regulated by p53-family proteins and induces apoptosis.
    Dohn M; Jiang J; Chen X
    Oncogene; 2001 Oct; 20(45):6503-15. PubMed ID: 11641774
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Gene expression of cyclin-dependent kinase subunit Cks2 is repressed by the tumor suppressor p53 but not by the related proteins p63 or p73.
    Rother K; Dengl M; Lorenz J; Tschöp K; Kirschner R; Mössner J; Engeland K
    FEBS Lett; 2007 Mar; 581(6):1166-72. PubMed ID: 17336302
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Role for the p53 homologue p73 in E2F-1-induced apoptosis.
    Irwin M; Marin MC; Phillips AC; Seelan RS; Smith DI; Liu W; Flores ER; Tsai KY; Jacks T; Vousden KH; Kaelin WG
    Nature; 2000 Oct; 407(6804):645-8. PubMed ID: 11034215
    [TBL] [Abstract][Full Text] [Related]  

  • 52. p73 expression and function in vestibular schwannoma.
    Ahmad ZK; Altuna X; Lopez JP; An Y; Wang-Rodriguez J; Juneja VR; Chen JS; Arandazi MJ; Aguilera J; Harris JP; Ongkeko WM
    Arch Otolaryngol Head Neck Surg; 2009 Jul; 135(7):662-9. PubMed ID: 19620587
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Absence of mutation of the p73 gene localized at chromosome 1p36.3 in hepatocellular carcinoma.
    Mihara M; Nimura Y; Ichimiya S; Sakiyama S; Kajikawa S; Adachi W; Amano J; Nakagawara A
    Br J Cancer; 1999 Jan; 79(1):164-7. PubMed ID: 10408709
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Acquired expression of transcriptionally active p73 in hepatocellular carcinoma cells.
    Sayan AE; Sayan BS; Findikli N; Ozturk M
    Oncogene; 2001 Aug; 20(37):5111-7. PubMed ID: 11526499
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [The structure and cellular regulation of p73: their implication in anticancer therapy].
    Zawacka-Pankau J; Maleńczyk K; Sznarkowska A
    Postepy Hig Med Dosw (Online); 2010 Feb; 64():78-86. PubMed ID: 20231765
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Transcriptional machinery of TNF-α-inducible YTH domain containing 2 (YTHDC2) gene.
    Tanabe A; Konno J; Tanikawa K; Sahara H
    Gene; 2014 Feb; 535(1):24-32. PubMed ID: 24269672
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Overexpression of the wild type p73 gene in breast cancer tissues and cell lines.
    Zaika AI; Kovalev S; Marchenko ND; Moll UM
    Cancer Res; 1999 Jul; 59(13):3257-63. PubMed ID: 10397274
    [TBL] [Abstract][Full Text] [Related]  

  • 58. p73 is transcriptionally regulated by DNA damage, p53, and p73.
    Chen X; Zheng Y; Zhu J; Jiang J; Wang J
    Oncogene; 2001 Feb; 20(6):769-74. PubMed ID: 11314010
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Direct transcriptional activation of human caspase-1 by tumor suppressor p53.
    Gupta S; Radha V; Furukawa Y; Swarup G
    J Biol Chem; 2001 Apr; 276(14):10585-8. PubMed ID: 11278253
    [TBL] [Abstract][Full Text] [Related]  

  • 60. DeltaNp73 can modulate the expression of various genes in a p53-independent fashion.
    Kartasheva NN; Lenz-Bauer C; Hartmann O; Schäfer H; Eilers M; Dobbelstein M
    Oncogene; 2003 Nov; 22(51):8246-54. PubMed ID: 14614448
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.